NYSE$OSCR
Oscar Health Inc · Q2 2022 earnings
Q2 2022 earnings · · Investor relations
Briefing
Reported a net loss of $112 million and a membership of 1,036,720, reflecting continued growth and strategic plan execution.
Oscar Health announced its Q2 2022 financial results, highlighted by an 84% year-over-year increase in membership, reaching 1,036,720. The company reported premiums earned of $995 million, an 88% increase YoY, and a net loss of $112 million, which increased by $39 million YoY. Oscar Health is reaffirming its 2022 outlook across all metrics and remains focused on achieving profitability for its Insurance product in 2023.
- Membership reached 1,036,720 as of June 30, 2022, an 84% increase year-over-year.
- Direct and assumed policy premiums totaled $1.7 billion, a 101% increase year-over-year.
- Premiums earned were $995 million, up 88% year-over-year.
- Net loss was $112 million, an increase of $39 million year-over-year.
Headline financials
Revenue & EPS history
Oscar Health · Revenue · Quarterly
$1.02B
Forward guidance
Oscar Health reaffirmed its 2022 outlook across all metrics.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q2 2022
+3.7%
Avg return
Earnings day
+5.6%
Avg return
5 days after
+7.5%
Avg return
30 days after
64%
16 / 25 earnings
Positive
+30.0%
Q1 2025
Best reaction
-23.9%
Q3 2022
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +2.7% | +22.6% | +36.6% | |
| Q4 2025 | +1.7% | +6.0% | +2.7% | |
| Q3 2025 | -2.8% | -12.8% | -1.5% | |
| Q1 2025 | +30.0% | +28.7% | +18.0% | |
| Q4 2024 | +3.1% | -3.7% | +4.5% | |
| Q3 2024 | -12.9% | -12.8% | +0.4% | |
| Q2 2024 | +7.2% | +4.4% | -1.4% | |
| Q1 2024 | +9.3% | +14.1% | +2.8% | |
| Q4 2023 | +22.7% | +27.5% | +7.7% | |
| Q3 2023 | +23.5% | +24.5% | +42.0% | |
| Q2 2023 | +8.6% | +1.9% | -10.5% | |
| Q1 2023 | -8.8% | -6.6% | +17.8% | |
| Q4 2022 | +21.0% | +36.2% | -3.9% | |
| Q3 2022 | -23.9% | -4.5% | -11.3% | |
| Q2 2022 | +19.9% | +21.1% | -3.7% | |
| Q1 2022 | -8.9% | -2.0% | -25.0% | |
| Q4 2019 | +6.3% | +2.5% | +39.1% | |
| Q4 2021 | +2.4% | +15.6% | +21.9% | |
| Q3 2020 | -2.4% | -6.3% | -12.7% | |
| Q3 2021 | -23.3% | -25.2% | -33.0% | |
| Q2 2020 | -16.4% | -11.8% | +19.4% | |
| Q2 2021 | -0.9% | -12.0% | +17.9% | |
| Q4 2020 | +15.2% | +14.5% | +23.1% | |
| Q1 2020 | +15.2% | +14.5% | +23.1% | |
| Q1 2021 | +3.6% | +4.2% | +14.0% |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro